Difference between revisions of "Ber-EP4"

From Libre Pathology
Jump to navigation Jump to search
Line 3: Line 3:
==Positive==
==Positive==
*[[Basal cell carcinoma]].
*[[Basal cell carcinoma]].
*[[Lung adenocarcinoma]] (55 of 59 cases<ref name=pmid9426522>{{Cite journal  | last1 = Ordóñez | first1 = NG. | title = Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature. | journal = Am J Clin Pathol | volume = 109 | issue = 1 | pages = 85-9 | month = Jan | year = 1998 | doi =  | PMID = 9426522 }}</ref>).
*[[Lung adenocarcinoma]] (55 positive of 59 cases<ref name=pmid9426522>{{Cite journal  | last1 = Ordóñez | first1 = NG. | title = Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature. | journal = Am J Clin Pathol | volume = 109 | issue = 1 | pages = 85-9 | month = Jan | year = 1998 | doi =  | PMID = 9426522 }}</ref>).


==Negative==
==Negative==

Revision as of 17:05, 15 May 2016

Ber-EP4 is a commonly available immunostain. It is directed against EpCam.[1]

Positive

Negative

See also

References

  1. Dasgeb, B.; Mohammadi, TM.; Mehregan, DR. (2013). "Use of Ber-EP4 and Epithelial Specific Antigen to Differentiate Clinical Simulators of Basal Cell Carcinoma.". Biomark Cancer 5: 7-11. doi:10.4137/BIC.S11856. PMID 24179394.
  2. 2.0 2.1 Ordóñez, NG. (Jan 1998). "Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature.". Am J Clin Pathol 109 (1): 85-9. PMID 9426522.
  3. Yu, L.; Galan, A.; McNiff, JM. (Oct 2009). "Caveats in BerEP4 staining to differentiate basal and squamous cell carcinoma.". J Cutan Pathol 36 (10): 1074-176. doi:10.1111/j.1600-0560.2008.01223.x. PMID 19187107.
  4. Sellheyer, K.; Nelson, P.; Kutzner, H.; Patel, RM. (Apr 2013). "The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.". J Cutan Pathol 40 (4): 363-70. doi:10.1111/cup.12085. PMID 23398472.